← Leaderboards
Rebecca Anne Gibson
Duke University
$120,931
Attributed
$120,931
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43.6K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$120,931 · 1
By mechanism
F30$120,931 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Dwight D Koeberl$10,403,079
- Priya S. Kishnani$1,826,678
- Yuan T Chen$792,683
- Priya S Kishnani$685,042
- Nenad Bursac$22,509,345
Others in their field
Other Emerging Leaders on “Diet Modification”
- Susan M Landau · University Of California Berkeley$47,252,026
- Danxia Yu · Vanderbilt University Medical Center$6,586,300
- Kristen Lyall · Drexel University$4,806,440
- Souheil Antoine Younes · Case Western Reserve University$3,776,712
- Catherine F Siengsukon · University Of Kansas Medical Center$3,672,490
- Rachel G Tabak · Washington University$3,658,098
Research focus
Diet ModificationDisease ModelDietary InterventionAccountingAlbuminsAdolescentBench To BedsideAdeno-Associated Viral VectorBreedingCapsidCareerCase StudyCellsCessation Of LifeChildChildhoodBlood GlucoseClinical TranslationClinical TrialsComplexCorn Starch PreparationDependovirusDiagnosisDisease Progression
Grant awards (3)
Liver-directed AAV gene therapy for PHKG2-Glycogen Storage Disease IX (GSD IX y2)$43,646
F30 · FY2023 · HD · contact PI
Liver-directed AAV gene therapy for PHKG2-Glycogen Storage Disease IX (GSD IX y2)$39,123
F30 · FY2022 · HD · contact PI
Liver-directed AAV gene therapy for PHKG2-Glycogen Storage Disease IX (GSD IX y2)$38,162
F30 · FY2021 · HD · contact PI